Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friederike Feldmann

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Mbio|January 11, 2022
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based VaccineWakako Furuyama, Kyle Shifflett, Amanda N Pinski, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccineWakako Furuyama, Kyle Shifflett, Amanda N Pinski, et al.
Science Translational Medicine|May 31, 2019
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challengeMichael K Lo, Friederike Feldmann, Joy M Gary, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Cell Death & Disease|June 30, 2017
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injurySofie Martens, Manhyung Jeong, Wulf Tonnus, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infectionKyle Rosenke, Kimberly Meade-White, Michael Letko, et al.
Emerging Microbes & Infections|November 30, 2020
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infectionKyle Rosenke, Kimberly Meade-White, Michael Letko, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaquesEmmie de Wit, Angela L Rasmussen, Darryl Falzarano, et al.
The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.
Science Advances|June 25, 2020
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaquesNeeltje van Doremalen, Elaine Haddock, Friederike Feldmann, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Mbio|January 11, 2022
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based VaccineWakako Furuyama, Kyle Shifflett, Amanda N Pinski, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccineWakako Furuyama, Kyle Shifflett, Amanda N Pinski, et al.
Science Translational Medicine|May 31, 2019
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challengeMichael K Lo, Friederike Feldmann, Joy M Gary, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Cell Death & Disease|June 30, 2017
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injurySofie Martens, Manhyung Jeong, Wulf Tonnus, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infectionKyle Rosenke, Kimberly Meade-White, Michael Letko, et al.
Emerging Microbes & Infections|November 30, 2020
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infectionKyle Rosenke, Kimberly Meade-White, Michael Letko, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaquesEmmie de Wit, Angela L Rasmussen, Darryl Falzarano, et al.
The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.
Science Advances|June 25, 2020
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaquesNeeltje van Doremalen, Elaine Haddock, Friederike Feldmann, et al.
Pageof 17